Our vitro experiments demonstrated that higher migratory potential of EC cell lines in response to chemotactic gradient of CCL20 suggests a role of CCR6-CCL20 axis in ESCC cell migration, and emphasizes the potential of CCR6 as a therapeutic target. Here, CCL20 is linked to esophageal squamous cell carcinoma.